Veracyte Announces In Vitro Diagnostic Agreement with Illumina to Broaden Availability of Its Tests for Patients GloballyBusiness Wire • 11/07/23
Seeking Clues to Illumina (ILMN) Q3 Earnings? A Peek Into Wall Street Projections for Key MetricsZacks Investment Research • 11/06/23
Earnings Preview: Illumina (ILMN) Q3 Earnings Expected to DeclineZacks Investment Research • 11/02/23
Illumina launches advanced liquid biopsy assay to enable comprehensive genomic profiling of solid tumorsPRNewsWire • 11/01/23
The Law Offices of Frank R. Cruz Announces Investigation of Illumina, Inc. (ILMN) on Behalf of InvestorsBusiness Wire • 10/27/23
GRAIL INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 10/19/23
Illumina to divest cancer test maker Grail if it does not win challenge in EU courtReuters • 10/13/23
Illumina ordered by European Commission to sell cancer test maker GrailProactive Investors • 10/12/23
GRAIL SHAREHOLDER INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 10/06/23
Illumina to Announce Third Quarter 2023 Financial Results on Thursday, November 9, 2023PRNewsWire • 10/05/23
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Illumina, Inc. and Encourages Investors with Losses to Contact the FirmAccesswire • 09/27/23